文献速递心力衰竭与心肌病

心力衰竭患者活动受限严重程度与不良结局的关系

Severity of mobility limitation and adverse outcomes in heart failure.
PubMed 文献 · Heart · 2026-06-11

该研究对两项日本前瞻性队列进行患者水平汇总分析,纳入2103例无排除标准的住院心衰患者,按出院时活动受限程度分为四级。随访2820.7人年期间发生998例复合终点事件,活动受限越严重,心衰再住院或全因死亡风险越高,呈明显剂量反应关系。

要点

  • 活动受限严重程度与心衰患者2年复合终点风险呈梯度关联。
  • 以独立户外行走为参照,无法行走者调整后HR达1.71(95%CI 1.34-2.20)。
  • 该分级可用于心衰患者的精细化风险分层。

核心结论

  • 心衰患者出院时活动受限严重程度与2年心衰再住院或全因死亡复合终点呈强且梯度的关联。

研究设计与样本

  • 两项日本前瞻性队列研究的患者水平汇总分析,纳入2103例无排除标准的住院心衰患者。
  • 出院时活动受限分为四级:I级独立户外行走,II级室内独立但户外需协助,III级室内需协助,IV级无法行走。
  • 主要终点为2年心衰再住院或全因死亡复合终点,调整年龄、性别、合并症、生物标志物和药物。

主要发现

  • 随访2820.7人年期间共发生998例复合终点事件。
  • 主要终点每100人年发生率随活动受限严重程度增加:I级24.9,II级47.0,III级59.3,IV级84.8(趋势p<0.001)。
  • 以I级为参照,调整后HR(95%CI)为II级1.22(1.04-1.45),III级1.39(1.11-1.73),IV级1.71(1.34-2.20)。
  • 死亡风险的梯度关联清晰,而单纯心衰再住院的关联较不明显,可能反映竞争性死亡风险。

临床怎么用

  • 可将出院时活动受限四级分类用于心衰患者风险分层,识别高危人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between its severity and adverse outcomes remains unquantified. METHODS: We conducted a patient-level pooled analysis of two prospective Japanese cohort studies, including 2103 hospitalised patients with HF with no exclusion criteria. Mobility limitation at discharge was categorised into four levels: category I (independent outdoor walking), category II (indoor independence but requiring outdoor assistance), category III (requiring indoor assistance) and category IV (unable to walk). The primary endpoint was a 2-year composite of HF rehospitalisation or all-cause mortality. Adjusted analyses accounted for age, sex, comorbidities, biomarkers and medications. RESULTS: Among 2820.7 person-years of follow-up, 998 composite outcomes occurred. Incidence rates per 100 person-years for the primary outcome increased with mobility limitation severity: 24.9 (category I), 47.0 (II), 59.3 (III) and 84.8 (IV) (p for trend <0.001). Adjusted HRs (95% CI) using category I as reference were 1.22 (95% CI 1.04 to 1.45) for II, 1.39 (95% CI 1.11 to 1.73) for III and 1.71 (95% CI 1.34 to 2.20) for IV. While the graded association was clear for mortality, it was less evident for HF rehospitalisation alone, likely reflecting competing mortality risks. CONCLUSIONS: This study demonstrates a strong and graded association between mobility limitation severity and adverse outcomes in HF, suggesting its utility for refined risk stratification.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Iwatsu, Takabayashi, Hamada, et al. Severity of mobility limitation and adverse outcomes in heart failure. Heart. 2026. PMID: 40533148. doi:10.1136/heartjnl-2024-325120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。